Antileishmanial and antibacterial activity of a new pyrazole derivative designated 4-[2-(1-(ethylamino)-2-methyl- propyl)phenyl]-3-(4-methyphenyl)-1-phenylpyrazole. 2006

Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
Laboratoire de Microbiologie et Biologie Moléculaire, Département de Biologie, Faculté des Sciences Ben M'sik-Casablanca, Université Hassan Il-Mohammedia, Casablanca, Morocco. dzainaba@yahoo.fr

Here, we report for the first time the synthesis and the antileishmanial activity of a new pyrazole derivative, namely 4-[2-(1-(ethylamino)-2-methylpropyl)phenyl]-3-(4-methyphenyl)-1-phenylpyrazole). Micromolar concentrations of this compound were found to inhibit the in vitro multiplication of Leishmania tropica, Leishmania major, and Leishmania infantum, three species causing different forms of leishmaniasis. Furthermore, the 50% inhibitory concentration (IC50) values for the compound are only slightly higher than those of amphotericin B, one of the most active antileishmanial agents used as a satisfactory substitute in cases not responding to pentostam. The IC50 values after 48 h for L. tropica, L. major, and L. infantum promastigote growth were 0.48 microg/mL, 0.63 microg/mL and 0.40 microg/mL, respectively for the compound, while they were 0.23 microg/mL, 0.29 microg/mL and 0.24 microg/mL, respectively for amphotericin B. We also tested this compound for its antibacterial activity against several bacteria. The strongest antibacterial activity was observed against Entrococcus feacalis and Staphylococcus aureus with a minimal inhibitory concentration (MIC) of 60 microg/mL.

UI MeSH Term Description Entries
D007895 Leishmania tropica A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects humans and rodents. This taxonomic complex includes species which cause a disease called Oriental sore which is a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World. Leishmania (Leishmania) tropica,Leishmania tropica minor,Leishmania leishmania tropica,Leishmania tropicas
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005021 Ethylamines Derivatives of ethylamine (the structural formula CH3CH2NH2).
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.

Related Publications

Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
October 2008, Acta crystallographica. Section E, Structure reports online,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
January 2005, Farmaco (Societa chimica italiana : 1989),
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
September 2022, IUCrData,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
May 2018, Scientific reports,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
August 2008, Acta crystallographica. Section E, Structure reports online,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
July 1970, Arzneimittel-Forschung,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
March 2002, Archiv der Pharmazie,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
May 2002, Archiv der Pharmazie,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
October 2011, Acta crystallographica. Section E, Structure reports online,
Zainaba Dardari, and Meryem Lemrani, and Abdelfatah Sebban, and Abdelmejid Bahloul, and Mohammed Hassar, and Said Kitane, and Mohammed Berrada, and Mohammed Boudouma
January 2010, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!